Cargando…

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes

In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lülf, Anna-Theresa, Freudenstein, Astrid, Marr, Lisa, Sutter, Gerd, Volz, Asisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111619/
https://www.ncbi.nlm.nih.gov/pubmed/27741426
http://dx.doi.org/10.1016/j.virol.2016.09.006
_version_ 1783513319720615936
author Lülf, Anna-Theresa
Freudenstein, Astrid
Marr, Lisa
Sutter, Gerd
Volz, Asisa
author_facet Lülf, Anna-Theresa
Freudenstein, Astrid
Marr, Lisa
Sutter, Gerd
Volz, Asisa
author_sort Lülf, Anna-Theresa
collection PubMed
description In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in fully permissive cell cultures. To evaluate the biological activity of the non-plaque-forming particles, we generated recombinant viruses expressing fluorescent reporter proteins under transcriptional control of specific viral early and late promoters. Live cell imaging and automated counting by fluorescent microscopy indicated that virtually all virus particles can enter cells and switch on viral gene expression. Although most of the non-plaque-forming infections are arrested at the level of viral early gene expression, we detected activation of late viral transcription in 10–20% of single infected cells. Thus, non-plaque-forming particles are biologically active, and likely contribute to the immunogenicity of vaccinia virus vaccines.
format Online
Article
Text
id pubmed-7111619
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71116192020-04-02 Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes Lülf, Anna-Theresa Freudenstein, Astrid Marr, Lisa Sutter, Gerd Volz, Asisa Virology Article In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in fully permissive cell cultures. To evaluate the biological activity of the non-plaque-forming particles, we generated recombinant viruses expressing fluorescent reporter proteins under transcriptional control of specific viral early and late promoters. Live cell imaging and automated counting by fluorescent microscopy indicated that virtually all virus particles can enter cells and switch on viral gene expression. Although most of the non-plaque-forming infections are arrested at the level of viral early gene expression, we detected activation of late viral transcription in 10–20% of single infected cells. Thus, non-plaque-forming particles are biologically active, and likely contribute to the immunogenicity of vaccinia virus vaccines. Elsevier Inc. 2016-12 2016-10-11 /pmc/articles/PMC7111619/ /pubmed/27741426 http://dx.doi.org/10.1016/j.virol.2016.09.006 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lülf, Anna-Theresa
Freudenstein, Astrid
Marr, Lisa
Sutter, Gerd
Volz, Asisa
Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title_full Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title_fullStr Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title_full_unstemmed Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title_short Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
title_sort non-plaque-forming virions of modified vaccinia virus ankara express viral genes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111619/
https://www.ncbi.nlm.nih.gov/pubmed/27741426
http://dx.doi.org/10.1016/j.virol.2016.09.006
work_keys_str_mv AT lulfannatheresa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes
AT freudensteinastrid nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes
AT marrlisa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes
AT suttergerd nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes
AT volzasisa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes